Michael Cook, 'Mucosa-mimetic materials to replace animal tissue in mucoadhesion research', poster presented at the Doctor Hadwen Trust Animal Replacement Science Conference, London, UK, 9 December, 2016.Pharmaceutical scientists often wish to design dosage forms which adhere to mucosal membranes to provide a localised effect. These “mucoadhesive” formulations are typically evaluated using ex vivo animal tissue, a large amount of which is sourced from laboratory animals slaughtered for that tissue . The authors aim to produce a synthetic alternative to this tissue, which frees scientists from the need to use laboratory animals and provides a substrate which is inexpensive and homogenous. A substrate containing 20 mol% N-acryloylglucosamine ...
Objectives: Here, we propose the application of a novel film-like chitosan (CH) strips as oral patc...
Transmucosal drug delivery systems can be an attractive alternative to conventional oral dosage form...
Tissue engineered human oral mucosa has the potential to fill tissue deficits caused by facial traum...
Mucoadhesion describes an attractive interaction between dosage form and mucosal membrane. The evalu...
Mucosa-mimetic polymeric hydrogels have been developed to replace the use of animal tissues as subst...
This is an Open Access article is licensed under a Creative Commons Attribution 3.0 Unported Licence...
Mucosa-mimetic materials are synthetic substrates which aim to replace animal tissue in mucoadhesion...
To reduce animal testing, there is a need to develop novel in-vitro models for evaluating the retent...
Mucoadhesion defined as attachment of synthetic or natural materials to mucosal tissues has been wid...
Well known mucoadhesive polymers such as Carbopol 974P and Pharmacoat 606 and three different mucosa...
Well known mucoadhesive polymers such as Carbopol 974P and Pharmacoat 606 and three different mucosa...
Oral tissue engineering aims to treat and fill tissue deficits caused by congenital defects, facial ...
Oral transmucosal administration, where drugs are absorbed directly through the non-keratinized, lin...
Mucoadhesion is the ability of materials to adhere to mucosal membranes in the human body and provid...
Objectives: Here, we propose the application of a novel film-like chitosan (CH) strips as oral patc...
Transmucosal drug delivery systems can be an attractive alternative to conventional oral dosage form...
Tissue engineered human oral mucosa has the potential to fill tissue deficits caused by facial traum...
Mucoadhesion describes an attractive interaction between dosage form and mucosal membrane. The evalu...
Mucosa-mimetic polymeric hydrogels have been developed to replace the use of animal tissues as subst...
This is an Open Access article is licensed under a Creative Commons Attribution 3.0 Unported Licence...
Mucosa-mimetic materials are synthetic substrates which aim to replace animal tissue in mucoadhesion...
To reduce animal testing, there is a need to develop novel in-vitro models for evaluating the retent...
Mucoadhesion defined as attachment of synthetic or natural materials to mucosal tissues has been wid...
Well known mucoadhesive polymers such as Carbopol 974P and Pharmacoat 606 and three different mucosa...
Well known mucoadhesive polymers such as Carbopol 974P and Pharmacoat 606 and three different mucosa...
Oral tissue engineering aims to treat and fill tissue deficits caused by congenital defects, facial ...
Oral transmucosal administration, where drugs are absorbed directly through the non-keratinized, lin...
Mucoadhesion is the ability of materials to adhere to mucosal membranes in the human body and provid...
Objectives: Here, we propose the application of a novel film-like chitosan (CH) strips as oral patc...
Transmucosal drug delivery systems can be an attractive alternative to conventional oral dosage form...
Tissue engineered human oral mucosa has the potential to fill tissue deficits caused by facial traum...